You can view the PDF here at any time:
To learn more about Prancer’s differentiators (speed, revolutionized study build, robust forecasting and post go-live flexibility), please visit our website or for more in-depth content visit our resources page.
Your clinical systems should never be a limiting factor and curb innovations in study designs, especially as the FDA is encouraging creativity. If the success of your study depends on being able to follow the science and change your protocol based on what is working, flexible cohort management is critical.